Hepatitis C virus core antigen in the management of patients treated with new direct-acting antivirals

被引:18
作者
Alados Arboledas, Juan Carlos [1 ]
Pavon Guerrero, Inmaculada [2 ]
Blanco Rodriguez, Maria Jose [2 ]
Torres Martos, Eva [1 ]
Belen Perez, Ana [3 ,4 ]
Cepero Leon, Cristina [2 ]
Sierra Sanchez, Jesus F. [5 ]
Lopez Prieto, Maria Dolores [1 ]
Chueca Porcuna, Natalia [3 ,4 ]
Ocete Mochon, Maria Dolores [6 ]
Macias, Juan [7 ]
de la Iglesia Salgado, Alberto [8 ]
Rodriguez Granger, Javier [9 ]
Delgado Fernandez, Marcial [10 ]
Guerrero Lozano, Inmaculada [11 ]
Reigadas Ramirez, Elena [12 ]
Rivero, Antonio [13 ]
Lozano Dominguez, Maria del Carmen [14 ]
Viciana, Isabel [15 ]
Galan Montemayor, Juan Carlos [16 ]
Garcia Garcia, Federico [3 ,4 ]
机构
[1] AGS Norte Cadiz, Microbiol Sect, Cadiz, Spain
[2] AGS Norte Cadiz, Digest Sect, Cadiz, Spain
[3] Hosp Univ San Cecilia, Microbiol Serv, Granada, Spain
[4] Inst Invest Biosanitario Ibs, Granada, Spain
[5] AGS Norte Cadiz, Serv Pharm, Cadiz, Spain
[6] H Gen, Microbiol Serv, Valencia, Spain
[7] H Valme, Infect Dis Unit, Seville, Spain
[8] H Infanta Elena, Microbiol Sect, Huelva, Spain
[9] H Virgen de las Nieves, Microbiol Serv, Granada, Spain
[10] H Carlos Haya, Infect Dis Unit, Malaga, Spain
[11] H Puerta del Mar, Microbiol Serv, Cadiz, Spain
[12] H Gregorio Maranon, Microbiol Serv, Madrid, Spain
[13] H Reina Sofia, Infect Dis Unit, Cordoba, Spain
[14] H Virgen del Rocio, Microbiol Serv, Seville, Spain
[15] H Virgen de la Victoria, Microbiol Serv, Malaga, Spain
[16] H Ramon y Cajal, Microbiol Serv, Madrid, Spain
关键词
Hepatitis C; Core antigen; Direct-acting antivirals; Viremia; Monitoring; HCV-RNA; ENZYME-IMMUNOASSAY; INFECTION; ASSAY; DIAGNOSIS; UTILITY;
D O I
10.1016/j.diagmicrobio.2017.06.006
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
We evaluated the utility of Architect core antigen assay Abbott Diagnostics (HCVAg) for monitoring patients with HCV infection and compared to HCV-RNA quantification (Cobas Ampliprep TaqMan-Roche Diagnostics). Samples from 262 patients were studied. Mean baseline HCV RNA and HCVAg levels were similar for responders (6.2 log IU/mL and 3.4 log fmol/L) and non-responders (6.1 log IU/mL and 32 log fmol/L), respectively. Only 10 patients failed to achieve SVR12 and all were detected by both assays. To evaluate HCVAg quantification as a tool for the detection of failure to DAAs, we performed a retrospective study of 132 non-responder patients. Mean HCV RNA and HCVAg levels at the time of detection of therapeutic failure were 5.88 +/- 0.97 log IU/mL and 3.19 +/- 0.79 log fmol/L, respectively. HCVAg (>3 fmol/L) was detected in 130/132 patients (98.5%). HCVAg assay was useful for patient selection and for evaluating virological response to DAAs in the real world. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码:29 / 34
页数:6
相关论文
共 26 条
[1]   Quantification of Core Antigen Monitors Efficacy of Direct-acting Antiviral Agents in Patients With Chronic Hepatitis C Virus Infection [J].
Aghemo, Alessio ;
Degasperi, Elisabetta ;
De Nicola, Stella ;
Bono, Patrizia ;
Orlandi, Anna ;
D'Ambrosio, Roberta ;
Soffredini, Roberta ;
Perbellini, Riccardo ;
Lunghi, Giovanna ;
Colombo, Massimo .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 14 (09) :1331-1336
[2]  
Aguilera Guirao A, 2014, PROCEDIMIENTOS MICRO
[3]  
Alados JC, 2016, ENFERM INFEC MICR CL, V34, P14
[4]  
[Anonymous], 2015, J HEPATOL, V2015
[5]  
[Anonymous], 2015, HEP C
[6]  
[Anonymous], 2016, J HEPATOL, V2016
[7]   Development of a simple and highly sensitive enzyme immunoassay for hepatitis C virus core antigen [J].
Aoyagi, K ;
Ohue, C ;
Iida, K ;
Kimura, T ;
Tanaka, E ;
Kiyosawa, K ;
Yagi, S .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (06) :1802-1808
[8]  
Chevaliez S, 2016, ANTIVIR THER
[9]   Hepatitis C Core Antigen Testing: A Reliable, Quick, and Potentially Cost-effective Alternative to Hepatitis C Polymerase Chain Reaction in Diagnosing Acute Hepatitis C Virus Infection [J].
Cresswell, Fiona V. ;
Fisher, Martin ;
Hughes, Daniel J. ;
Shaw, Simon G. ;
Homer, Gary ;
Hassan-Ibrahim, Mohammed O. .
CLINICAL INFECTIOUS DISEASES, 2015, 60 (02) :263-266
[10]  
Curry MP, 2015, HEPATOLOGY, V62, p721A